Physician profile
Dillon J Smith
NPI 1780087502
$2,133.51
in general payments reported to CMS, 2019-2025
10 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,774 · 2023: $93.08 · 2024: $88.77 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $1,666.39 | 2022 | |
| Zimmer Biomet Holdings, INC. | $140.05 | 2022-2024 | Comprehensive, Juggerknotless Soft Anchor |
| Depuy Synthes Sales INC. | $129.65 | 2025 | Dynacord, Gryphon Orthocord, Healix Knotless Peek |
| Smith+Nephew, INC. | $59.14 | 2022-2023 | Or3o Dual Mobility |
| Ferring Pharmaceuticals INC. | $39.06 | 2024 | Euflexxa |
| Ucb, INC. | $29.35 | 2025 | Bimzelx |
| Heron Therapeutics, INC. | $19.07 | 2025 | Zynrelef |
| Bioventus LLC | $18.68 | 2023 | Durolane |
| Curonix LLC | $16.42 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Endo Pharmaceuticals INC. | $15.70 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dillon Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.